INS and early-onset autosomal dominant Alzheimer disease: Additionally, gut microbiota produce SCFAs, such as acetate, propionate, and butyrate, which not only enhance gut barrier and immune function, reducing the transfer of endogenous bacterial components, but also lower insulin resistance, reduce oxidative stress, and maintain central nervous system homeostasis, positively impacting diseases like stroke and Alzheimer’s disease (27).